JP2017519818A5 - - Google Patents

Download PDF

Info

Publication number
JP2017519818A5
JP2017519818A5 JP2017516254A JP2017516254A JP2017519818A5 JP 2017519818 A5 JP2017519818 A5 JP 2017519818A5 JP 2017516254 A JP2017516254 A JP 2017516254A JP 2017516254 A JP2017516254 A JP 2017516254A JP 2017519818 A5 JP2017519818 A5 JP 2017519818A5
Authority
JP
Japan
Prior art keywords
phenyl
benzo
imidazol
butyl
tert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017516254A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017519818A (ja
JP6612857B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/033962 external-priority patent/WO2015187818A1/en
Publication of JP2017519818A publication Critical patent/JP2017519818A/ja
Publication of JP2017519818A5 publication Critical patent/JP2017519818A5/ja
Application granted granted Critical
Publication of JP6612857B2 publication Critical patent/JP6612857B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017516254A 2014-06-03 2015-06-03 ベンゾイミダゾールアナログおよび関連方法 Active JP6612857B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462007321P 2014-06-03 2014-06-03
US62/007,321 2014-06-03
PCT/US2015/033962 WO2015187818A1 (en) 2014-06-03 2015-06-03 Benzimidazole analogues and related methods

Publications (3)

Publication Number Publication Date
JP2017519818A JP2017519818A (ja) 2017-07-20
JP2017519818A5 true JP2017519818A5 (enExample) 2018-07-19
JP6612857B2 JP6612857B2 (ja) 2019-11-27

Family

ID=54767311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017516254A Active JP6612857B2 (ja) 2014-06-03 2015-06-03 ベンゾイミダゾールアナログおよび関連方法

Country Status (7)

Country Link
US (1) US9988371B2 (enExample)
EP (1) EP3152194B8 (enExample)
JP (1) JP6612857B2 (enExample)
CN (1) CN107074778B (enExample)
AU (1) AU2015271692B2 (enExample)
ES (1) ES2742192T3 (enExample)
WO (1) WO2015187818A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107176951A (zh) * 2016-03-11 2017-09-19 恩瑞生物医药科技（上海）有限公司 一种脲类化合物、其制备方法及其医药用途
JP6997876B2 (ja) 2018-01-18 2022-02-04 アレイ バイオファーマ インコーポレイテッド Ｒｅｔキナーゼ阻害剤としての置換ピラゾリル［４，３－ｃ］ピリジン化合物
WO2019143977A1 (en) 2018-01-18 2019-07-25 Array Biopharma Inc. Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors
CN113164476A (zh) * 2018-09-28 2021-07-23 代表亚利桑那大学的亚利桑那校董会 Dyrk1/clk的小分子抑制剂及其用途
WO2020168963A1 (zh) * 2019-02-18 2020-08-27 深圳市塔吉瑞生物医药有限公司 取代的芳香稠合环衍生物及其组合物及用途
WO2020181232A1 (en) 2019-03-06 2020-09-10 C4 Therapeutics, Inc. Heterocyclic compounds for medical treatment
CN112300106B (zh) * 2020-10-30 2023-03-03 徐州医科大学 一种蛋白激酶抑制剂及制备方法与应用
CN112778294A (zh) * 2021-01-07 2021-05-11 苏州安睿药业有限公司 5-氨基异噁唑衍生物及其在制备多激酶抑制剂中的应用
CN115198256A (zh) * 2022-07-13 2022-10-18 上海天承化学有限公司 一种用于聚酰亚胺薄膜的化学镀铜用还原液及其制备方法和应用
WO2024206989A2 (en) * 2023-03-30 2024-10-03 Bioventures, Llc Flt3 inhibitors and methods of using the same
CN121081464B (zh) * 2025-11-10 2026-02-03 广州市第一人民医院（广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院） 小分子抑制剂pz1在治疗kit突变阳性急性髓系白血病中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030225054A1 (en) 2002-06-03 2003-12-04 Jingwu Duan Combined use of tace inhibitors and COX2 inhibitors as anti-inflammatory agents
CA2545711A1 (en) * 2003-11-13 2005-06-02 Ambit Biosciences Corporation Urea derivatives as kinase modulators
DOP2006000051A (es) * 2005-02-24 2006-08-31 Lilly Co Eli Inhibidores de vegf-r2 y métodos
GB0507575D0 (en) * 2005-04-14 2005-05-18 Novartis Ag Organic compounds
AU2010280712B2 (en) * 2009-08-07 2015-10-22 Janssen Sciences Ireland Uc Bis-benzimidazole derivatives as hepatitis C virus inhibitors
UA108211C2 (uk) * 2009-11-04 2015-04-10 Янссен Рід Айрленд Бензімідазолімідазольні похідні
WO2011150201A2 (en) * 2010-05-27 2011-12-01 Ambit Biosciences Corporation Azolyl amide compounds and methods of use thereof
WO2012088266A2 (en) * 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
EP2736330A4 (en) * 2011-07-29 2015-05-27 Tempero Pharmaceuticals Inc COMPOUNDS AND METHODS

Similar Documents

Publication Publication Date Title
JP2017519818A5 (enExample)
US9815846B2 (en) TrkA kinase inhibitors, compositions and methods thereof
US10435388B2 (en) Selective inhibitors of clinically important mutants of the EGFR tyrosine kinase
EP3122344B1 (en) Trka kinase inhibitors, compositions and methods thereof
KR20150135359A (ko) 브로모도메인-함유 단백질의 억제를 위한 방법 및 조성물
JP2020503299A5 (enExample)
EP3648753A1 (en) Selective inhibitors of clinically important mutants of the egfr tyrosine kinase
AU2013207252A1 (en) Carbamate compounds and pharmaceutical compositions thereof
EA035036B1 (ru) Производные пиразоло[1,5-а]пиразин-4-ила в качестве ингибиторов янус-киназы (jak)
JP2023511096A (ja) タンパク質キナ－ゼ阻害活性を有する７－アミノ－３，４－ジヒドロピリミドピリミジン－２－オン誘導体およびこれを含む治療用薬学組成物
BRPI0511072B1 (pt) compostos derivados de alquinila como moduladores dos receptores de glutamato metabotróbico, seus usos e suas composições farmacêuticas
WO2006071940A2 (en) Enzyme modulators and treatments
JP2009521492A (ja) オーロラキナーゼのアザインドール阻害薬
WO2014062667A1 (en) Phenyl linked quinolinyl modulators of ror-gamma-t
JPWO2009131173A1 (ja) ２−アミノキナゾリン誘導体
RU2014132044A (ru) Гетероциклические производные в качестве рецепторов, ассоциированных со следовыми аминами (taars)
JP2016537324A (ja) シクロペンチルベンズアミド誘導体及びそれらの精神障害及び認知障害の治療への使用
CN103370324A (zh) 作为蛋白激酶抑制剂的芳炔类衍生物及其医疗用途
CA2834101A1 (en) Novel indole or indazole derivative or salt thereof
JP7507749B2 (ja) Ｎａｄｐｈオキシダーゼ阻害剤としての新規化合物
JP2019001715A (ja) 三環性化合物
JP2024527565A (ja) Ｍａｐ４ｋ１阻害物質として使用するためのピリミジン化合物
JP2024517715A (ja) Ｔｒｅｘ１のモジュレーター
EA035585B1 (ru) Аллостерические модуляторы никотиновых ацетилхолиновых рецепторов